Journals 'Fess Up to Authors' Financial Conflicts

File Photo Major peer-reviewed science journals are toughening rules that require authors to say when they have a financial stake in topics of their articles. The moves from Science and Nature come in response to letters exposing what critics say were a series of publications by people whose pocketbooks could have been hurt or helped by articles published in the journals. Nature's new policy takes effect in October, while Science has underlined its existing policy and asked its editorial boar

Written byPeg Brickley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Major peer-reviewed science journals are toughening rules that require authors to say when they have a financial stake in topics of their articles. The moves from Science and Nature come in response to letters exposing what critics say were a series of publications by people whose pocketbooks could have been hurt or helped by articles published in the journals. Nature's new policy takes effect in October, while Science has underlined its existing policy and asked its editorial board to ponder the issue.

Science recently made its existing policy more explicit by requiring all authors to disclose all sources of funding for their research and to do so in a brief statement, suitable for publication within the article, according to executive editor Monica Bradford. But more sweeping changes may be in the works, she says, including a new policy for publishing the declarations of financial interests that are required of authors, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies